We also observed that hTREX84 expression is enhanced in estrogen receptor (ER) negative breast cancer [11], while constitutive activation of NF-κB has been shown to be associated with more aggressive breast cancers [40], [42], [54]. Here, ESR1 is linked to breast carcinoma.